Richard Douglas, Director at Aldeyra Therapeutics, Inc. (ALDX), bought 40,000 shares at $4.50 ($180K) on 2017-02-17, disclosed to the SEC on 2017-02-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MXCT | BUY | 2023-03-30 | $346K | — | Filing → |
| MXCT | BUY | 2021-11-23 | $445K | — | Filing → |
| ALDX | BUY | 2020-03-17 | $110K | — | Filing → |